acyclovir
Generic: acyclovir
Labeler: remedyrepack inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
remedyrepack inc.
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70518-4186
Product ID
70518-4186_3ff281aa-ddd3-a441-e063-6394a90a6946
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA074891
Listing Expiration
2026-12-31
Marketing Start
2024-09-25
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
705184186
Hyphenated Format
70518-4186
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA074891 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 10 TABLET in 1 BOTTLE, PLASTIC (70518-4186-0)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ff281aa-ddd3-a441-e063-6394a90a6946", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["c1744e01-0e40-4851-8ffc-c3bf29dd7c2b"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE, PLASTIC (70518-4186-0)", "package_ndc": "70518-4186-0", "marketing_start_date": "20240925"}], "brand_name": "ACYCLOVIR", "product_id": "70518-4186_3ff281aa-ddd3-a441-e063-6394a90a6946", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-4186", "generic_name": "ACYCLOVIR", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA074891", "marketing_category": "ANDA", "marketing_start_date": "20240925", "listing_expiration_date": "20261231"}